✦ LIBER ✦

Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trial

✍ Scribed by Weisz, Giora; Farzaneh-Far, Ramin; Ben-Yehuda, Ori; DeBruyne, Bernard; Montalescot, Gilles; Lerman, Amir; Mahmud, Ehtisham; Alexander, Karen P.; Ohman, E. Magnus; White, Harvey D.; Olmsted, Ann; Walker, Gennyne A.; Stone, Gregg W.

Book ID: 122999391
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 249 KB
Volume: 166
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2013.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of the Presence and Extent of Inc

Impact of the Presence and Extent of Incomplete Angiographic Revascularization After Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial

✍ Rosner, G. F.; Kirtane, A. J.; Genereux, P.; Lansky, A. J.; Cristea, E.; Gersh, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 499 KB

Design and rationale of the TOTAL trial:

Design and rationale of the TOTAL trial: A randomized trial of routine aspiration ThrOmbecTomy with percutaneous coronary intervention (PCI) versus PCI ALone in patients with ST-elevation myocardial infarction undergoing primary PCI

✍ Jolly, Sanjit S.; Cairns, John; Yusuf, Salim; Meeks, Brandi; Shestakovska, Olga; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 174 KB

PREDICTION OF 5-YEAR CLINICAL OUTCOMES U

PREDICTION OF 5-YEAR CLINICAL OUTCOMES USING THE SYNTAX SCORE IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FROM THE SIROLIMUS-ELUTING STENT COMPARED WITH PACLITAXEL-ELUTING STENT FOR CORONARY REVASCULARIZATION (SIRTAX) TRIAL

✍ Girasis, Chrysafios; Garg, Scot; Räber, Lorenz; Sarno, Giovanna; Morel, Marie-an 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Geographical Differences in the Rates of

Geographical Differences in the Rates of Angiographic Restenosis and Ischemia-Driven Target Vessel Revascularization After Percutaneous Coronary Interventions: Results From the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial

✍ Mandeep Singh; Brent A. Williams; Bernard J. Gersh; Robyn L. McClelland; Kalon K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Outcomes of Patients Treated With Triple

Outcomes of Patients Treated With Triple Antithrombotic Therapy After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial)

✍ Eugenia Nikolsky; Roxana Mehran; George D. Dangas; Jennifer Yu; Helen Parise; Ke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 767 KB

Development and Validation of a Risk Sco

Development and Validation of a Risk Scoring Model to Predict Net Adverse Cardiovascular Outcomes after Primary Percutaneous Coronary Intervention in Patients Pretreated with 600 mg Clopidogrel: Rationale and Design of the RISK-PCI Study

✍ IGOR MRDOVIC; LIDIJA SAVIC; JOVAN PERUNICIC; MILIKA ASANIN; RATKO LASICA; JELENA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB